COMP <GO>
CDLX vs TWAV // REVENUE GROWTH (YOY)
Cardlytics Inc. (NASDAQ) VS. TaoWeave Inc. (NASDAQ) • 15-METRIC TALLY: CDLX 2
— TWAV 1
■ METRIC PARITY
LAST: $1.64 (+2.50%) • MKT CAP: $9.7M
revenue-growth
-16.90%
LAST: $1.45 (-0.34%) • MKT CAP: $5.6M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDLX VS. TWAV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDLX | TWAV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -48.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -49.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -16.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | CDLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.3 | 39.9 | -7.56 | TWAV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.7M | $5.6M | $4.0M | CDLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDLX REV | TWAV REV | CDLX GROSS % | TWAV GROSS % | CDLX FCF | TWAV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $212.3M | $0 | — | — | $8.8M | -$3.0M |
| FY 2024 | $255.6M | $0 | — | — | -$10.4M | -$3.4M |
| FY 2023 | $285.4M | $0 | — | — | -$185.0K | -$3.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDLX // BETA —
TWAV // BETA —